 | Up a level |
Fruchart, Jean-Charles and Santos, Raul D. and Aguilar-Salinas, Carlos and Aikawa, Masanori and Al Rasadi, Khalid and Amarenco, Pierre and Barter, Philip J. and Ceska, Richard and Corsini, Alberto and Després, Jean-Pierre and Duriez, Patrick and Eckel, Robert H. and Ezhov, Marat V. and Farnier, Michel and Ginsberg, Henry N. and Hermans, Michel P. and Ishibashi, Shun and Karpe, Fredrik and Kodama, Tatsuhiko and Koenig, Wolfgang and Krempf, Michel and Lim, Soo and Lorenzatti, Alberto J. and McPherson, Ruth and Nuñez-Cortes, Jesus Millan and Nordestgaard, Børge G. and Ogawa, Hisao and Packard, Chris J. and Plutzky, Jorge and Ponte-Negretti, Carlos I. and Pradhan, Aruna and Ray, Kausik K. and Reiner, Željko and Ridker, Paul M. and Ruscica, Massimiliano and Sadikot, Shaukat and Shimano, Hitoshi and Sritara, Piyamitr and Stock, Jane K. and Su, Ta-Chen and Susekov, Andrey V. and Tartar, André and Taskinen, Marja-Riitta and Tenenbaum, Alexander and Tokgözoğlu, Lale S. and Tomlinson, Brian and Tybjærg-Hansen, Anne and Valensi, Paul and Vrablík, Michal and Wahli, Walter and Watts, Gerald F. and Yamashita, Shizuya and Yokote, Koutaro and Zambon, Alberto and Libby, Peter (2019) The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential. Cardiovascular Diabetology, 18 (1). ISSN 1475-2840
